Rareview Systematic Equity ETF (BATS:RSEE – Get Free Report) was the target of a significant drop in short interest in the month of October. As of October 15th, there was short interest totaling 4,518 shares, a drop of 80.6% from the September 30th total of 23,260 shares. Currently, 0.3% of the company’s stock are short sold. Based on an average daily volume of 9,631 shares, the days-to-cover ratio is presently 0.5 days.
Rareview Systematic Equity ETF Stock Performance
Shares of RSEE opened at $38.00 on Tuesday. The company’s 50 day moving average price is $39.08 and its 200 day moving average price is $37.41. Rareview Systematic Equity ETF has a 52 week low of $31.83 and a 52 week high of $40.38. The company has a market capitalization of $68.40 million, a PE ratio of 21.27 and a beta of 0.69.
Institutional Investors Weigh In On Rareview Systematic Equity ETF
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Janney Montgomery Scott LLC boosted its stake in shares of Rareview Systematic Equity ETF by 34.1% during the 1st quarter. Janney Montgomery Scott LLC now owns 57,854 shares of the company’s stock valued at $1,889,000 after buying an additional 14,698 shares during the period. Farther Finance Advisors LLC grew its holdings in shares of Rareview Systematic Equity ETF by 691.7% during the 3rd quarter. Farther Finance Advisors LLC now owns 3,254 shares of the company’s stock valued at $126,000 after acquiring an additional 2,843 shares in the last quarter. Finally, Bank of New York Mellon Corp purchased a new position in shares of Rareview Systematic Equity ETF during the 1st quarter valued at $266,000.
Rareview Systematic Equity ETF Company Profile
The Rareview Systematic Equity ETF (RSEE) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed fund-of-funds that employs a long\u002Fshort systematic strategy to provide exposure to global equity markets. RSEE was launched on Jan 20, 2022 and is managed by Rareview Funds.
Further Reading
- Five stocks we like better than Rareview Systematic Equity ETF
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Rareview Systematic Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rareview Systematic Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
